Hyderabad: A new study has revealed that over 80% of people with fatty liver in Hyderabad are diabetic, while three-fourths of hypertensive patients were found to have fatty liver. The `Apollo Hospitals’ Health of the Nation 2025' study has highlighted …

… Muthini said. He said pharmacists remain an underutilised workforce despite … , promoting safe and rational drug use, and contributing to … tuberculosis, diabetes, cardiovascular diseases and other non-communicable conditions, pharmacists are key players …

… and vomiting caused by cancer treatment, and for anorexia, too. … a heart attack and other cardiovascular diseases. (Freepik) Also Read | AIIMS … the risk of dying from cardiovascular disease He added, “This isn … cannabis use - and treating it like the risk …

… and proven, cost-effective treatments, we can work to … burden. The number of cardiovascular disease deaths worldwide has risen … outside of the most developed settings even after … the Global Burden of Cardiovascular Diseases Collaboration is an alliance …

Cardiovascular disease (CVD) is the leading … the Global Burden of Cardiovascular Diseases highlights this growing challenge … hypertension are diagnosed, 42% receive treatment, and 21% achieve blood … and the EU is developing fiscal and regulatory measures to …

… 3 ASCENT-GYN-01 trial (NCT06486441), which is … A history of significant cardiovascular disease Prior exposure to a … 39;re at risk of developing treatment-related neutropenia. [In accordance … .fda.gov/drugs/resources-information-approved-drugs/fda- …

… as Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Alnylam Pharmaceuticals, Inc. … protein. The first drug approved in this setting … PFE / BBIO pills that stabilize the protein … pipeline of programs across cardiovascular disease, neurology, liver disease, …

… the FDA approved four peptide or oligonucleotide drugs, … peptide drugs used for cancer, diabetes and cardiovascular diseases. … involved in drug discovery and drug development, and commercialization … owing to well-developed pharmaceutical industry, sophisticated …

… That cohort of 10 drugs ended up with average price … is limited to patients with cardiovascular disease. For Eli Lilly, that … playing field toward its rival treatments, Mounjaro and Zepbound, if … ’s Austedo, used to treat Huntington’s and tardive dyskinesia …

… PELD) yields favorable treatment outcomes for degenerative spinal … ’s efficacy in treating the pathological changes … , diabetes mellitus or cardiovascular disease), or those exhibiting … SN etiology, including developmental factors, degenerative conditions, …